cymbopogon citratus leaf extract oxidized é seguro durante a gravidez?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard for CAS 84238-19-7 was identified. PubMed/CosIng searches do not reveal ingredient-specific reproductive toxicity data. Topical cosmetic use may lead to low but measurable systemic exposure due to volatile constituents (e.g., citral), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised hazard), PubChem/CosIng entries, PubMed (no ingredient-specific repro studies), EWG (ingredient profile).
Related ingredients
Frequently asked questions
- cymbopogon citratus leaf extract oxidized é seguro durante a gravidez?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard for CAS 84238-19-7 was identified. PubMed/CosIng searches do not reveal ingredient-specific reproductive toxicity data. Topical cosmetic use may lead to low but measurable systemic exposure due to volatile constituents (e.g., citral), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised hazard), PubChem/CosIng entries, PubMed (no ingredient-specific repro studies), EWG (ingredient profile).
- cymbopogon citratus leaf extract oxidized é seguro durante a amamentação?
- No evidence of reproductive or lactation-specific toxicity for this ingredient in authoritative assessments. Systemic transfer into breastmilk is theoretical but not demonstrated for this extract; exposure scored as low (1) given potential for low systemic absorption of volatile constituents with topical use. Sources: ECHA Annex VI, PubChem, CosIng, PubMed (no specific studies).
- cymbopogon citratus leaf extract oxidized é seguro para a pele do bebê?
- No infant-specific toxicity data were found and no harmonised reproductive/ developmental classification applies. Because infant skin has higher permeability and surface-area-to-weight ratio and lemongrass extracts can contain absorbable volatile constituents (e.g., citral), exposure was increased by +1 for 0–3 yr (adult exposure low → infant moderate). Note: primary concern for topical use is skin sensitization (citral), not documented developmental toxicity for this extract. Sources: CosIng, PubChem, PubMed, EWG, ECHA (no harmonised classification).
- Como o VeriMom pontua cymbopogon citratus leaf extract oxidized?
- O VeriMom pontua cymbopogon citratus leaf extract oxidized em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a cymbopogon citratus leaf extract oxidized na gravidez?
- Veja nossa lista curada de alternativas seguras a cymbopogon citratus leaf extract oxidized com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.